Predictors of hepatitis A vaccination among young children in the United States
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Predictors of hepatitis A vaccination among young children in the United States
  • Published Date:

    Feb 23 2011

  • Source:
    Vaccine. 29(17):3254-3259.
  • Language:
    English
Filetype[PDF-553.53 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 158.29 KB]
    Personal Author:
    Lu, Peng-jun; Byrd, Kathy K.; Murphy, Trudy V.;
    Published Date:
    Mar 21 2013
    Source:
    Vaccine. 31(19):2348-2357.
    Description:
    BackgroundSince 1996, hepatitis A vaccine (HepA) has been recommended for adults at increased risk for infection including travelers to high or intermediate hepatitis A endemic countries. In 2009, travel outside the United States and Canada was the m...
    File Type:
    Filetype[PDF - 158.29 KB]
  2. Filetype[PDF - 677.23 KB]
    Personal Author:
    Nelson, Noele P.; Yankey, David; Singleton, James A.; Elam-Evans, Laurie D.;
    Published Date:
    February 12 2018
    Source:
    Vaccine. 36(12):1650-1659
    Description:
    BackgroundThe hepatitis A (HepA) vaccine was recommended by the Advisory Committee on Immunization Practices (ACIP) incrementally from 1996 to 1999. In 2006, HepA vaccine was recommended (1) universally for children aged 12–23 months, (2) for perso...
    File Type:
    Filetype[PDF - 677.23 KB]
  3. Filetype[PDF - 367.48 KB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    January 12, 2001
    Source:
    MMWR. Morbidity and mortality weekly report. 2001; 50(1):7-10, 19.
    Description:
    Each year, CDC's Advisory Committee on Immunization Practices (ACIP) reviews the recommended childhood immunization schedule to ensure that it remains current with changes in manufacturers' vaccine formulations, revisions in recommendations for the u...
    Status:
    superseded
    File Type:
    Filetype[PDF - 367.48 KB]
  4. Filetype[PDF - 138.06 KB]
    Personal Author:
    Hofmeister, Megan G.; McCready, Jill A.; Link-Gelles, Ruth; Cramer, Blanche Greene; Nolen, Leisha D.; Garstang, Helentina; Foster, Monique A.;
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.. Centers for Dsease Control and Prevention (U.S.). Epidemic Intelligence Service.. Center for Global Health (U.S.). Division of Global Health Protection.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Preparedness and Emerging Infections..
    Published Date:
    May 04 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(17):504-505.
    File Type:
    Filetype[PDF - 138.06 KB]
  5. Filetype[PDF - 394.11 KB]
    Personal Author:
    Bell, Beth P.; Margolis, Harold S.; Shapiro, Craig N.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.). Division of Viral and Rckettsial Diseases..
    Published Date:
    December 27, 1996
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1996; 45(RR-15):1-30.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 45, no. RR-15
    Description:
    This report provides recommendations for use of the newly licensed hepatitis A vaccines (HAVRIX, manufactured by SmithKline Beecham Biologicals, and VAQTA, manufactured by Merck & Company, Inc.) in persons > or = 2 years of age and updates previous r...
    Status:
    superseded
    File Type:
    Filetype[PDF - 394.11 KB]